SLC35B2

Adenosine 3'-phospho 5'-phosphosulfate transporter 1 · Q8TB61 · SLC35B2 on Sugi Atlas →

0 patent compounds predicted against SLC35B2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC35B2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Age on the Renal Clearance of Adefovir PHASE4WITHDRAWN
Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity PHASE4COMPLETED
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
Preventing Acute Kidney Injury (AKI) in Pediatric Patients PHASE3UNKNOWN
Reformulated F75 Milk to Treat Severe Acute Malnutrition PHASE2/PHASE3COMPLETED
[18F]MC225-PET in Neurodegenerative Disease PHASE1/PHASE2UNKNOWN
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia PHASE1/PHASE2RECRUITING
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia PHASE1/PHASE2COMPLETED
Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® PHASE1/PHASE2COMPLETED
Genotype Stratified Pharmacokinetic Study of Montelukast PHASE1COMPLETED
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors PHASE1COMPLETED
Pharmacokinetic Study to Characterize Individual Metabolic Profile PHASE1COMPLETED
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias PHASE1COMPLETED
N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia PHASE1COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters EARLY_PHASE1COMPLETED
Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I EARLY_PHASE1COMPLETED
The Effect of a Diet Based on Low Sodium and Slowly Absorbed Carbohydrates on the Incidence of Refeeding Syndrome in Patients With Head and Neck Cancer nanCOMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Renal Transporters After Renal Transplantation nanUNKNOWN
I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers nanCOMPLETED
Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients nanCOMPLETED
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs nanCOMPLETED
A Proof-of-concept Study Evaluating the Microbiota-gut-brain Axis nanRECRUITING
Plant-based Diets and Body Weight and Selected Metabolic Parameters Management in Obese Patients. nanCOMPLETED
Chest Wall Deformities in Children - Epidemiological Data nanCOMPLETED
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
Cardiovascular Effects of Empagliflozine nanUNKNOWN
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital nanUNKNOWN
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin nanUNKNOWN
Effect of Pharmacogenetics on Imatinib Plasma Level and Response nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC35B2 binder may also engage these)

ProteinNameSimilarity
Q5R9A1 1.000 Q5R9A1 →
Q91ZN5 0.999 Q91ZN5 →
Q6NM25 0.963 Q6NM25 →
Q6NMB6 0.959 Q6NMB6 →
Q8CD26 0.956 Q8CD26 →
P0C6B1 0.954 P0C6B1 →
SLC35E1 Solute carrier family 35 member E1 0.950 landscape →
Q8H184 0.941 Q8H184 →
Q3U481 0.938 Q3U481 →
Q96HV5 0.938 Q96HV5 →
Q9D8U2 0.937 Q9D8U2 →
Q8IVJ1 0.936 Q8IVJ1 →
Q5R839 0.935 Q5R839 →
DGAT1 Diacylglycerol O-acyltransferase 1 0.935 landscape →
Q8R070 0.934 Q8R070 →
A2VE61 0.933 A2VE61 →
Q9LNK7 0.933 Q9LNK7 →
Q7RTT9 0.932 Q7RTT9 →
Q5F3N0 0.932 Q5F3N0 →
Q9GMF1 0.930 Q9GMF1 →
Q6ZP29 0.930 Q6ZP29 →
B0BMY1 0.929 B0BMY1 →
Q8BJA2 0.929 Q8BJA2 →
Q9Z2A7 0.928 Q9Z2A7 →
Q8TED4 0.928 Q8TED4 →
Q1LZI2 0.928 Q1LZI2 →
A0A3Q2HW92 0.928 A0A3Q2HW92 →
Q08D99 0.928 Q08D99 →
Q9WU81 0.928 Q9WU81 →
Q6NUT3 0.928 Q6NUT3 →